Related Experiment Video
Updated: Aug 12, 2026
08:47
Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
Published on: February 10, 2012
Pharmacological approaches to smoking cessation
1Department of Public Health and Preventive Medicine, Loma Linda University, CA 92350.
American Journal of Preventive Medicine
|January 1, 1993
Summary
Smoking cessation efforts face challenges, as current decline rates must double to meet Healthy People 2000 goals. This review examines pharmacological interventions, including nicotine replacement and antidepressants, to overcome physiological barriers.
Area of Science:
- Public Health
- Pharmacology
- Clinical Trials
Background:
- Current adult smoking prevalence in the U.S. is 28%, declining at 0.5% annually.
- This rate of decline is insufficient to meet the Healthy People 2000 goal of 15% adult smoking prevalence.
- Physiological barriers significantly impede smoking cessation success.
Purpose of the Study:
- To review the effectiveness of pharmacological interventions for smoking cessation.
- To evaluate both older and recent pharmacological approaches.
- To discuss the design and results of relevant clinical trials.
Main Methods:
- Literature review of smoking cessation interventions.
- Inclusion of studies on nicotine replacement therapy (NRT).
- Analysis of trials investigating clonidine, antianxiety agents, and antidepressants.
Main Results:
- Effectiveness of various pharmacological agents in aiding smoking cessation is examined.
- Comparison of efficacy between different classes of drugs.
- Insights into the design and outcomes of clinical trials for smoking cessation pharmacotherapy.
Conclusions:
- Pharmacological interventions play a crucial role in reducing physiological barriers to smoking cessation.
- Continued research and clinical trials are essential to optimize pharmacotherapy for smoking cessation.
- Achieving public health goals for smoking reduction requires enhanced cessation strategies.
Related Concept Videos
01:17Drug Dependence
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
01:23Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
01:25Adrenergic Agonists: Indirect-Acting Agents
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
01:27CNS Depressants: Alcohol and Nicotine
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation